DeuteRx has pioneered DECS (deuterium-enabled chiral switching) to create differentiated new chemical entities (NCEs) with new composition of matter patent protection and the potential for an expedited and derisked development path. Our success includes 4 M&A transactions, a Phase 2b NASH drug candidate (PXL065 in collaboration with Poxel SA), surprising discoveries with molecular glue degraders, and >50 issued patents.
| Website | http://www.deuterx.com |
| Revenue | $1 million |
| Employees | 5 (3 on RocketReach) |
| Founded | 2012 |
| Address | 15 Constitution Ave Suite 1A, Bedford, New Hampshire 03110, US |
| Phone | (978) 662-5287 |
| Technologies |
HTML
,
G Suite
,
Bootstrap
+4 more
(view full list)
|
| Industry | Biotechnology Research, Drug Stores & Pharmacies, Biotechnology, Retail, Science and Engineering, Pharmaceutical, Health Care, Therapeutics |
| Keywords | Biopharmaceutical, Pharmaceutical Research, Pharmaceutical Science, Drug Development, Pharmaceutical Technology, Drug Discovery, Medicinal Chemistry, Biotechnology, Drug Efficacy, Novel Drug Delivery, Clinical Research |
| Competitors | Roche, Amgen, Bristol Myers Squibb, Novartis, AbbVie, Genentech, Regeneron, Sorrento Therapeutics, Inc., Zymeworks Inc., Lilly India +39 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular DeuteRx employee's phone or email?
The DeuteRx annual revenue was $1 million in 2026.
Sheila Dewitt is the Chair, President, CEO and Founder of DeuteRx.
3 people are employed at DeuteRx.
DeuteRx is based in Bedford, New Hampshire.
The NAICS codes for DeuteRx are [32541, 32, 3254, 325].
The SIC codes for DeuteRx are [283, 28].